A research team has developed an innovative biomimetic dual-mode magnetic resonance imaging (MRI) nanoprobe for detecting early-stage liver fibrosis in non-alcoholic fatty liver disease (NAFLD).
Dual-mode MRI nanoprobe mimics biological processes to pinpoint early fibrosis in fatty liver disease
